A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome
Year: 2016
Type: article
Study design: Clinical Trial
Institutions: Washington University in St. Louis, Mayo Clinic in Arizona
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Celgene
OpenAlex ID: W2342965927
